Launch of Thomson Clinical Xpert Delivers Essential Medical Information to Physicians via PDAs

THOMSONThomson, a leading provider of clinical and management decision support solutions to healthcare professionals, announced the launch of Thomson Clinical Xpert™ for PDAs. A powerful new medical reference and decision-support tool, Thomson Clinical Xpert puts authoritative drug, disease and laboratory information instantly into the hands of physicians and other prescribers, nurses, pharmacists, and clinical trainees, helping them to make important decisions at the point of care, and reducing the chances of medical errors.

The launch of this new application, which will help address quality and safety issues such as drug interactions, comes at a time when medical errors and patient safety continue to be a national concern – one underscored by a recent report from the Institute of Medicine that noted medication errors alone still harm 1.5 million patients per year.

Whether in the hospital or a medical office, Thomson Clinical Xpert enhances healthcare professionals' ability to make the right decisions quickly, helping to avoid errors and improve the quality of care. Thomson, known and trusted by healthcare professionals as the company that produces the Physicians' Desk Reference® (PDR), developed Thomson Clinical Xpert to give healthcare professionals fast, convenient access to the evidence-based information they need to support or confirm diagnosis and treatment decisions. This release extends the commitment of Thomson to help improve medication safety wherever it is needed. Future Thomson Clinical Xpert releases will feature desktop and online access to additional workflow tools for medication reconciliation, pharmacy intervention and reporting, coding compliance and executable order sets.

Dr. Jerry Osheroff, chief clinical informatics officer at Thomson and lead author of the American Medical Informatics Association Roadmap for National Action on Clinical Decision Support, said Thomson Clinical Xpert will be a useful tool in efforts to improve the safety and quality of healthcare. "We know that clinicians are committed to eliminating errors and ensuring the most effective care for their patients," he said. "Thomson Clinical Xpert improves point-of-care access to consistent, authoritative medical knowledge for all those who play a direct role in patient care, reducing the risk of medical errors. The ultimate beneficiary is, of course, the patient."

Thomson Clinical Xpert features premium content from Thomson Micromedex, one of the most respected providers of evidence-based clinical information. Experienced physicians, pharmacists, toxicologists, nurses and other healthcare professionals at Micromedex develop and review Thomson Clinical Xpert content, giving clinicians information of unparalleled authority and accuracy, including:

  • A searchable database of more than 4,000 drugs with comprehensive indications, dosage and interactions information
  • Details on more than 400 laboratory tests and their interpretations
  • Toxicology reports on more than 200 of the most common poisons and drug overdoses
  • A comprehensive disease database that offers differential diagnoses, therapeutics and evidence-based recommendation ratings
  • Detailed information about alternative medicines

Thomson Clinical Xpert also features drug interaction tools, convenient medical calculators and "Xpert Alerts"— electronic advisories regarding key drug changes or treatment studies delivered directly to users PDA, desktop or PDR.net account.

Delaware family practitioner John Hale, M.D., said he uses Thomson Clinical Xpert on a daily basis to look up dosages, maximum dosages and drug interactions. "I use my PDA in the exam room without having to leave the room, or the discussion to look up pertinent information," he noted. "I also have used the lab and diagnosis sections while making rounds in the hospital. Having a library like this in my pocket PC is a real time saver."

Osheroff noted that a 2005 study found that more than 87 percent of physicians reported using PDAs, and as many as 50 percent say they frequently refer to PDA-stored clinical information. "As more and more clinicians rely on PDAs, combining the convenience of a PDA with comprehensive, accurate medical information provided by a trusted source such Thomson is going to be an invaluable tool to support clinical practice," he said.

For further information, please visit: www.thomsonclinicalxpert.com

About The Thomson Corporation
The Thomson Corporation (www.thomson.com) is a global leader in providing essential electronic workflow solutions to business and professional customers. With operational headquarters in Stamford, Conn., Thomson provides value-added information, software tools and applications to more than 20 million users in the fields of law, tax, accounting, financial services, scientific research and healthcare. The Corporation's common shares are listed on the New York and Toronto stock exchanges (NYSE: TOC; TSX: TOC).

Most Popular Now

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

OmicsFootPrint: Mayo Clinic's AI To…

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool...

Testing AI with AI: Ensuring Effective A…

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialled in South Australian hospitals actually has the potential to assist doctors and...

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...